AKUMS DRUGS & PHARMACEUTICALS
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
| Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹30 Cr | ₹15 Cr | ₹1.50 Cr |
| Equity - Issued | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
| Equity Paid Up | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹3,016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr |
| Securities Premium | ₹1,084 Cr | ₹127 Cr | ₹127 Cr | ₹127 Cr | ₹128 Cr |
| Capital Reserves | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹103 Cr |
| Profit & Loss Account Balance | ₹1,829 Cr | ₹631 Cr | ₹639 Cr | ₹558 Cr | ₹832 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr |
| Reserve excluding Revaluation Reserve | ₹3,016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹3,047 Cr | ₹709 Cr | ₹717 Cr | ₹622 Cr | ₹885 Cr |
| Minority Interest | ₹17 Cr | ₹11 Cr | ₹6.19 Cr | ₹3.20 Cr | ₹2.29 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | ₹78 Cr | ₹115 Cr | ₹13 Cr | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | ₹124 Cr | ₹149 Cr | ₹20 Cr | ₹9.85 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | ₹-46 Cr | ₹-34 Cr | ₹-6.69 Cr | ₹-9.85 Cr |
| Unsecured Loans | - | - | - | - | ₹1.16 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | ₹1.16 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-189 Cr | ₹-111 Cr | ₹-6.22 Cr | ₹20 Cr | ₹27 Cr |
| Deferred Tax Assets | ₹270 Cr | ₹194 Cr | ₹82 Cr | ₹43 Cr | ₹40 Cr |
| Deferred Tax Liability | ₹81 Cr | ₹83 Cr | ₹76 Cr | ₹64 Cr | ₹66 Cr |
| Other Long Term Liabilities | ₹102 Cr | ₹1,464 Cr | ₹1,111 Cr | ₹1,095 Cr | ₹637 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹36 Cr | ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr |
| Total Non-Current Liabilities | ₹-52 Cr | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹643 Cr | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr |
| Sundry Creditors | ₹643 Cr | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹180 Cr | ₹253 Cr | ₹246 Cr | ₹238 Cr | ₹84 Cr |
| Bank Overdraft / Short term credit | - | - | ₹3.77 Cr | ₹4.81 Cr | ₹1.66 Cr |
| Advances received from customers | ₹23 Cr | ₹112 Cr | ₹108 Cr | ₹145 Cr | ₹17 Cr |
| Interest Accrued But Not Due | - | - | - | - | ₹0.42 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹157 Cr | ₹141 Cr | ₹134 Cr | ₹88 Cr | ₹65 Cr |
| Short Term Borrowings | ₹14 Cr | ₹368 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
| Secured ST Loans repayable on Demands | ₹14 Cr | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
| Working Capital Loans- Sec | ₹14 Cr | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-14 Cr | ₹-167 Cr | ₹-388 Cr | ₹-338 Cr | ₹-86 Cr |
| Short Term Provisions | ₹58 Cr | ₹58 Cr | ₹65 Cr | ₹107 Cr | ₹68 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹0.40 Cr | ₹1.44 Cr | ₹19 Cr | ₹48 Cr | ₹29 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹57 Cr | ₹57 Cr | ₹46 Cr | ₹59 Cr | ₹39 Cr |
| Total Current Liabilities | ₹894 Cr | ₹1,211 Cr | ₹1,266 Cr | ₹1,272 Cr | ₹580 Cr |
| Total Liabilities | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr |
| ASSETS | |||||
| Gross Block | ₹2,252 Cr | ₹1,893 Cr | ₹1,715 Cr | ₹1,542 Cr | ₹1,325 Cr |
| Less: Accumulated Depreciation | ₹854 Cr | ₹702 Cr | ₹617 Cr | ₹521 Cr | ₹421 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,397 Cr | ₹1,191 Cr | ₹1,097 Cr | ₹1,021 Cr | ₹904 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹160 Cr | ₹195 Cr | ₹103 Cr | ₹31 Cr | ₹17 Cr |
| Non Current Investments | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
| Long Term Investment | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr |
| Long Term Loans & Advances | ₹61 Cr | ₹56 Cr | ₹96 Cr | ₹86 Cr | ₹44 Cr |
| Other Non Current Assets | ₹9.06 Cr | ₹9.74 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr |
| Total Non-Current Assets | ₹1,631 Cr | ₹1,452 Cr | ₹1,311 Cr | ₹1,159 Cr | ₹995 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | ₹19 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | ₹19 Cr |
| Inventories | ₹681 Cr | ₹630 Cr | ₹730 Cr | ₹722 Cr | ₹430 Cr |
| Raw Materials | ₹338 Cr | ₹304 Cr | ₹362 Cr | ₹335 Cr | ₹177 Cr |
| Work-in Progress | ₹75 Cr | ₹71 Cr | ₹77 Cr | ₹67 Cr | ₹34 Cr |
| Finished Goods | ₹127 Cr | ₹109 Cr | ₹130 Cr | ₹160 Cr | ₹97 Cr |
| Packing Materials | ₹84 Cr | ₹65 Cr | ₹82 Cr | ₹81 Cr | ₹50 Cr |
| Stores  and Spare | ₹15 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹6.56 Cr |
| Other Inventory | ₹41 Cr | ₹68 Cr | ₹67 Cr | ₹67 Cr | ₹65 Cr |
| Sundry Debtors | ₹770 Cr | ₹834 Cr | ₹845 Cr | ₹884 Cr | ₹531 Cr |
| Debtors more than Six months | ₹106 Cr | ₹107 Cr | ₹151 Cr | ₹83 Cr | ₹545 Cr |
| Debtors Others | ₹714 Cr | ₹750 Cr | ₹709 Cr | ₹819 Cr | - |
| Cash and Bank | ₹576 Cr | ₹277 Cr | ₹150 Cr | ₹103 Cr | ₹68 Cr |
| Cash in hand | ₹0.50 Cr | ₹0.33 Cr | ₹0.25 Cr | ₹0.41 Cr | ₹0.53 Cr |
| Balances at Bank | ₹576 Cr | ₹277 Cr | ₹150 Cr | ₹102 Cr | ₹67 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹32 Cr | ₹30 Cr | ₹15 Cr | ₹9.49 Cr | ₹10 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹16 Cr | ₹13 Cr | ₹9.10 Cr | ₹7.94 Cr | ₹6.47 Cr |
| Other current_assets | ₹15 Cr | ₹17 Cr | ₹5.61 Cr | ₹1.55 Cr | ₹3.82 Cr |
| Short Term Loans and Advances | ₹215 Cr | ₹169 Cr | ₹139 Cr | ₹145 Cr | ₹99 Cr |
| Advances recoverable in cash or in kind | ₹31 Cr | ₹20 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr |
| Advance income tax and TDS | - | - | ₹11 Cr | - | ₹0.16 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹184 Cr | ₹149 Cr | ₹103 Cr | ₹125 Cr | ₹82 Cr |
| Total Current Assets | ₹2,275 Cr | ₹1,941 Cr | ₹1,879 Cr | ₹1,864 Cr | ₹1,157 Cr |
| Net Current Assets (Including Current Investments) | ₹1,381 Cr | ₹730 Cr | ₹613 Cr | ₹592 Cr | ₹577 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr |
| Contingent Liabilities | ₹92 Cr | ₹89 Cr | ₹82 Cr | ₹98 Cr | ₹22 Cr |
| Total Debt | ₹14 Cr | ₹492 Cr | ₹537 Cr | ₹358 Cr | ₹97 Cr |
| Book Value | 199.01 | 49.59 | 50.13 | 86.95 | 6,801.28 |
| Adjusted Book Value | 199.01 | 49.59 | 50.13 | 43.47 | 61.83 |
Compare Balance Sheet of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,412.0 Cr | 1.1% | 5.6% | -48.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 1.1% |
5.6% |
-48.1% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses